[Federal Register: April 26, 2004 (Volume 69, Number 80)]
[Notices]               
[Page 22563]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr26ap04-109]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated November 14, 2003, and published in the Federal 
Register on December 2, 2003 (68 FR 67475), Lifepoint, Inc., 10400 
Trademark Street, Rancho Cucamonga, California 91730, made application 
by renewal to the Drug Enforcement Administration for registration as a 
bulk manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
3,4-Methylenedioxyamphetamine (7400).......  I
3,4-Methylenedioxy-N-ethylamphetamine        I
 (7404).
3,4-Methylenedioxymethamphetamine (7405)...  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Phencyclidine (7471).......................  II
Benzoylecogonine (9180)....................  II
Morphine (9300)............................  II
------------------------------------------------------------------------

    The firm plans to produce small quantities of controlled substances 
for use in drug test kits.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Lifepoint, Inc. to manufacture the 
listed controlled substances is consistent with the public interest at 
this time. DEA has investigated Lifepoint, Inc. to ensure that the 
company's registration is consistent with the public interest. This 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with State and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 
0.104, the Deputy Assistant Administrator, Office of Diversion Control, 
hereby orders that the application submitted by the above firm for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed is granted.

    Dated: April 1, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-9329 Filed 4-23-04; 8:45 am]

BILLING CODE 4410-09-M